TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$2.63
+0.29 (+12.39%)
As of Feb 8, 2:31 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.37M 1.35M 1.27M
Net Income -80,240 -84,207 -82,182
EPS
Profit Margin -5.8% -6.2% -6.5%
Rev Growth +9.2% +20.4% +2.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.43M 2.88M 2.33M
Total Equity 1.80M 1.84M 1.81M
D/E Ratio 1.35 1.56 1.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -110,674 -111,401 -119,566
Free Cash Flow -110,675 -113,905 -126,135